Many of Eli Lilly’s acquisitions this year double down in areas where the company is already a player, such as cancer and inflammatory disorders. Lilly is now broadening its scope to a new area, ...

Takeda Pharmaceutical is bolstering its pipeline in a big way, committing $1.2 billion for rights to two late-stage Innovent Biologics cancer drugs and securing an exclusive option to license an early ...

Three health systems are suing CVS Health, alleging the company and its pharmacy subsidiaries diverted roughly $250 million in savings from the 340B Drug Pricing Program. The 340B program was ...

On Wednesday, 60 organizations representing providers and patients with cancer submitted a letter to Robert F. Kennedy Jr., secretary of Health and Human Services, urging him to protect the U.S.

At Wayne General Hospital in rural Mississippi, clinicians say AI-powered stethoscope usage is helping them detect heart problems earlier in patients who often have limited access to specialists. The ...

Most disputes between pharmaceutical companies and generic drugmakers end in settlements. Five years of class-action litigation over a Takeda Pharmaceutical gastrointestinal drug culminated this week ...

Employer advocates said Cost Plus Wellness could help spur more direct contracting and transparency in healthcare, though ...

Many people view precision medicine as healthcare’s next frontier. The field promises a future where treatments are tailored to each patient’s unique genes, biology and disease risk, with the goal of ...

Providers are voicing concern over HHS Secretary Robert F. Kennedy Jr.’s firing of the vice chairs of the U.S. Preventive Services Task Force (USPSTF). They say the move raises fresh questions about ...

Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is ...

As hospitals brace for rising costs tied to President Donald Trump’s proposed tariffs, a new report from the American Hospital Association reveals that drugs and supplies are just part of the problem.